The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women

Journal of B.U.ON.

Volumn 18, Issue 2, 2013, Pages 335-341

  Turkoz, F P ^a   Solak, M ^a   Petekkaya, I ^a   Keskin, O ^a   Kertmen, N ^a   Sarici, F ^a   Arik, Z ^a   Babacan, T ^a   Ozisik, Y ^a   Altundag, Kadri ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Breast cancer; Molecular subtypes; Obesity; Premenopausal; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; BREAST CANCER; CANCER CLASSIFICATION; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HORMONAL REGULATION; HUMAN; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; OBESITY; OVERALL SURVIVAL; PREDICTIVE VALUE; PREMENOPAUSE; PROTEIN EXPRESSION; SURVIVAL RATE;

BODY MASS INDEX; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; OBESITY; PREMENOPAUSE; PROPORTIONAL HAZARDS MODELS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84879594813     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Key TJ, Appleby PN, Reeves GK et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003; 95:1218-1226. (Pubitemid 37069552)
2. Yumuk PF, Dane F, Yumuk VD et al. Impact of body mass index on cancer developments J BUON 2008; 13:55-59. (Pubitemid 351460876)
3. Van den Brandt PA, Spiegelman D, Yaun SS et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000; 152:514-527.
4. McTiernan A, Rajan KB, Tworoger SS et al. Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol 2003; 21:1961-1966. (Pubitemid 46606384)
5. Key TJ, Appleby PN, Barnes I et al. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002; 94:606-616. (Pubitemid 34498648)
6. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 2004;96:1856-1865. (Pubitemid 40081323)
7. Berstad P, Coates RJ, Bernstein L et al. A Case-Control Study of Body Mass Index and Breast Cancer Risk in White and African-American Women. Cancer Epidemiol Biomarkers Prev 2010; 19:1532-1544.
8. Baer HJ, Tworoger SS, Hankinson SE, Willett WC. Body Fatness at Young Ages and Risk of Breast Cancer Throughout Life. Am J Epidemiol 2010; 171:1183-1194.
9. Goodwin PJ, Ennis M, Pritchard KI et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 2002; 20:42-51. (Pubitemid 34032594)
10. Ishikawa M, Kitayama J, Nagawa H. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 2004; 10:4325-4331. (Pubitemid 38878870)
11. Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, Weight Gain, and Survival After Breast Cancer Diagnosis. J Clin Oncol 2005; 23: 1370-1378.
12. Calle EE, Rodriguez C, Walker-Thurmond K et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348:1625-1638. (Pubitemid 36459468)
13. Probst-Hensch NM, Steiner JH, Schraml P et al. IGFBP2 and IGFBP3 protein expressions in human breast cancer: association with hormonal factors and obesity. Clin Cancer Res 2010; 16:1025-1032.
14. Daling JR, Malone KE, Doody DR et al. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 2001; 92:720-729. (Pubitemid 32783055)
15. Berclaz G, Li S, Price KN et al. Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol 2004; 15:875-884. (Pubitemid 39004342)
16. Whiteman MK, Hillis SD, Curtis KM et al. Body mass and mortality after breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev 2005; 14:2009-2014. (Pubitemid 41161216)
17. Porter GA, Inglis KM, Wood LA, Veugelers PJ. Effect of obesity on presentation of breast cancer. Ann Surg Oncol 2006; 13:327-332. (Pubitemid 43255915)
18. Chen X, Lu W, Zheng W et al. Obesity and weight change in relation to breast cancer survival. Breast Cancer Res Treat 2010; 122:823-833.
19. Loi S, Milne RL, Friedlander ML et al. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2005; 14:1686-1691. (Pubitemid 40995080)
20. Rosenberg L, Czene K, Hall P. Obesity and poor breast cancer prognosis: an illusion because of hormone replacement therapy? Br J Cancer 2009; 100:1486-1491.
21. Demirkan B, Alacacioglu A, Yilmaz U. Relation of Body Mass Index (BMI) to Disease Free (DFS) and Distant Disease Free Survivals (DDFS) Among Turkish Women with Operable Breast Carcinoma. Jpn J Clin Oncol 2007; 37: 256-265. (Pubitemid 47096437)
22. Dignam JJ, Wieand K, Johnson KA et al. Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 2003; 95: 1467-1476. (Pubitemid 37279332)
23. Baer HJ, Colditz GA, Rosner B et al. Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women: a prospective cohort study. Breast Cancer Res 2007; 7: 314-325.
24. Cleveland RJ, Eng SM, Abrahamson PE et al. Weight gain prior to diagnosis and survival from breast cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 1803-1811. (Pubitemid 47450510)
25. Millikan RC, Newman B, Tse CK et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 2008; 109:123-139. (Pubitemid 351538762)
26. Maehle BO, Tretli S, Skjaerven R, Thorsen T. Premorbid body weight and its relations to primary tumour diameter in breast cancer patients; its dependence on estrogen and progesterone receptor status. Breast Cancer Res Treat 2001; 68: 159-169. (Pubitemid 32964313)
27. Vona-Davis L, Rose DP. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 2007; 14: 189-206. (Pubitemid 47242622)
28. Gupta PB, Proia D, Cingoz O et al. Systematic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. Cancer Res 2007;67:2062-2071. (Pubitemid 46424224)
29. Rose DP, Vona-Davis L. Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas 2010; 66: 33-38.
30. Karaduman M, Bilici A, Ozet A et al. Tissue leptin levels in patients with breast cancer. J BUON 2010; 15: 369-372.
31. Rose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 2004; 5: 153-165. (Pubitemid 38998240)
32. Liu CL, Chang YC, Cheng SP et al. The roles of serum leptin concentration and polymorphism in leptin receptor gene at codon 109 in breast cancer. Oncology 2007; 72: 75-81.
33. Sonmez B, Seker M, Bilici A et al. Is there any correlation among adiponectin levels in serum, tumor tissue and normal tissue of the same patients with breast cancer? J BUON 2011; 16: 227-232.
34. Honda H, Ohi Y, Umekita Y et al. Obesity Affects Expression of Progesterone Receptors and Node Metastasis of Mammary Carcinomas in postmenopausal Women Without a Family History. Pathol Int 1999; 49: 198-202. (Pubitemid 29210545)
35. Sellahewa C, Nightingale P, Carmichael AR. Obesity and HER 2 overexpression: a common factor for poor prognosis of breast cancer. Int Semin Surg Oncol 2008; 5: 2. (doi: 10.1186/1477-7800-5-2)
36. Ewertz M, Jensen MB, Gunnarsdottir KA et al. Effect of obesity on prognosis after early-stage brest cancer. J Clin Oncol 2004; 29: 25-31.
37. Abrahamson PE, Gammon MD, Lund MJ et al. General and abdominal obesity and survival among young women with breast cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 1871-1877. (Pubitemid 44664262)
38. Reeves GK, Patterson J, Vessey MP et al. Hormonal and other factors in relation to survival among breast cancer patients. Int J Cancer 2000; 89: 293-299. (Pubitemid 30430747)
39. Morabia A, Ross A, Curtin F et al. Relation of BMI to a dual-energy X-ray absorptiometry measure of fatness. Br J Nutr 1999; 82: 49-55. (Pubitemid 29377975)